Mouwasat Medical Services Company

SASE:4002 Aktierapport

Börsvärde: ر.س16.7b

Mouwasat Medical Services Framtida tillväxt

Future kriterier kontrolleras 3/6

Mouwasat Medical Services förväntas öka intäkter och intäkter med 13.7% respektive 11% per år. EPS förväntas tillväxt med 14.4% per år. Avkastningen på eget kapital förväntas bli 21.5% om 3 år.

Viktig information

13.7%

Tillväxttakt i vinsten

14.4%

Tillväxttakt för EPS

Healthcare vinsttillväxt13.3%
Intäkternas tillväxttakt11.0%
Framtida avkastning på eget kapital21.5%
Bevakning av analytiker

Good

Senast uppdaterad05 Mar 2025

Senaste uppdateringarna om framtida tillväxt

Recent updates

Investors Appear Satisfied With Mouwasat Medical Services Company's (TADAWUL:4002) Prospects

Feb 14
Investors Appear Satisfied With Mouwasat Medical Services Company's (TADAWUL:4002) Prospects

The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing

Dec 12
The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing

Do Mouwasat Medical Services' (TADAWUL:4002) Earnings Warrant Your Attention?

Sep 30
Do Mouwasat Medical Services' (TADAWUL:4002) Earnings Warrant Your Attention?

The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing

Sep 12
The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing

Mouwasat Medical Services Company's (TADAWUL:4002) Popularity With Investors Is Clear

Aug 06
Mouwasat Medical Services Company's (TADAWUL:4002) Popularity With Investors Is Clear

Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?

Jul 01
Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?

Mouwasat Medical Services Company's (TADAWUL:4002) Popularity With Investors Is Clear

Apr 23
Mouwasat Medical Services Company's (TADAWUL:4002) Popularity With Investors Is Clear

Here's Why We Think Mouwasat Medical Services (TADAWUL:4002) Might Deserve Your Attention Today

Mar 18
Here's Why We Think Mouwasat Medical Services (TADAWUL:4002) Might Deserve Your Attention Today

Slowing Rates Of Return At Mouwasat Medical Services (TADAWUL:4002) Leave Little Room For Excitement

Jan 23
Slowing Rates Of Return At Mouwasat Medical Services (TADAWUL:4002) Leave Little Room For Excitement

Here's Why Mouwasat Medical Services (TADAWUL:4002) Has Caught The Eye Of Investors

Dec 17
Here's Why Mouwasat Medical Services (TADAWUL:4002) Has Caught The Eye Of Investors

Mouwasat Medical Services (TADAWUL:4002) Has Some Way To Go To Become A Multi-Bagger

Oct 05
Mouwasat Medical Services (TADAWUL:4002) Has Some Way To Go To Become A Multi-Bagger

Should You Be Adding Mouwasat Medical Services (TADAWUL:4002) To Your Watchlist Today?

Sep 17
Should You Be Adding Mouwasat Medical Services (TADAWUL:4002) To Your Watchlist Today?

The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing

Jul 03
The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing

Is Now The Time To Put Mouwasat Medical Services (TADAWUL:4002) On Your Watchlist?

Jun 12
Is Now The Time To Put Mouwasat Medical Services (TADAWUL:4002) On Your Watchlist?

Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down

Feb 24
Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down

Mouwasat Medical Services Company's (TADAWUL:4002) Intrinsic Value Is Potentially 25% Below Its Share Price

Jan 18
Mouwasat Medical Services Company's (TADAWUL:4002) Intrinsic Value Is Potentially 25% Below Its Share Price

Return Trends At Mouwasat Medical Services (TADAWUL:4002) Aren't Appealing

Nov 24
Return Trends At Mouwasat Medical Services (TADAWUL:4002) Aren't Appealing

Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down

Aug 24
Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down

A Look At The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)

Jul 01
A Look At The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)

Time To Worry? Analysts Just Downgraded Their Mouwasat Medical Services Company (TADAWUL:4002) Outlook

May 23
Time To Worry? Analysts Just Downgraded Their Mouwasat Medical Services Company (TADAWUL:4002) Outlook

Mouwasat Medical Services (TADAWUL:4002) Will Pay A Larger Dividend Than Last Year At ر.س2.75

Apr 29
Mouwasat Medical Services (TADAWUL:4002) Will Pay A Larger Dividend Than Last Year At ر.س2.75

Mouwasat Medical Services (TADAWUL:4002) Is Increasing Its Dividend To ر.س2.75

Apr 15
Mouwasat Medical Services (TADAWUL:4002) Is Increasing Its Dividend To ر.س2.75

Investors Will Want Mouwasat Medical Services' (TADAWUL:4002) Growth In ROCE To Persist

Mar 17
Investors Will Want Mouwasat Medical Services' (TADAWUL:4002) Growth In ROCE To Persist

Calculating The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)

Mar 02
Calculating The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)

If You Like EPS Growth Then Check Out Mouwasat Medical Services (TADAWUL:4002) Before It's Too Late

Feb 15
If You Like EPS Growth Then Check Out Mouwasat Medical Services (TADAWUL:4002) Before It's Too Late

The Return Trends At Mouwasat Medical Services (TADAWUL:4002) Look Promising

Dec 06
The Return Trends At Mouwasat Medical Services (TADAWUL:4002) Look Promising

Do Mouwasat Medical Services's (TADAWUL:4002) Earnings Warrant Your Attention?

Nov 16
Do Mouwasat Medical Services's (TADAWUL:4002) Earnings Warrant Your Attention?

Mouwasat Medical Services (TADAWUL:4002) Is Achieving High Returns On Its Capital

Aug 29
Mouwasat Medical Services (TADAWUL:4002) Is Achieving High Returns On Its Capital

Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?

Aug 12
Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?

Is Mouwasat Medical Services Company (TADAWUL:4002) Expensive For A Reason? A Look At Its Intrinsic Value

Jun 29
Is Mouwasat Medical Services Company (TADAWUL:4002) Expensive For A Reason? A Look At Its Intrinsic Value

Mouwasat Medical Services' (TADAWUL:4002) Returns On Capital Are Heading Higher

May 26
Mouwasat Medical Services' (TADAWUL:4002) Returns On Capital Are Heading Higher

Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?

May 11
Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?

Is It Worth Buying Mouwasat Medical Services Company (TADAWUL:4002) For Its 1.4% Dividend Yield?

Apr 13
Is It Worth Buying Mouwasat Medical Services Company (TADAWUL:4002) For Its 1.4% Dividend Yield?

Estimating The Intrinsic Value Of Mouwasat Medical Services Company (TADAWUL:4002)

Mar 16
Estimating The Intrinsic Value Of Mouwasat Medical Services Company (TADAWUL:4002)

Is Mouwasat Medical Services Company's (TADAWUL:4002) Latest Stock Performance Being Led By Its Strong Fundamentals?

Mar 02
Is Mouwasat Medical Services Company's (TADAWUL:4002) Latest Stock Performance Being Led By Its Strong Fundamentals?

Is Mouwasat Medical Services (TADAWUL:4002) A Future Multi-bagger?

Feb 13
Is Mouwasat Medical Services (TADAWUL:4002) A Future Multi-bagger?

Here's Why I Think Mouwasat Medical Services (TADAWUL:4002) Is An Interesting Stock

Feb 01
Here's Why I Think Mouwasat Medical Services (TADAWUL:4002) Is An Interesting Stock

What Kind Of Shareholders Hold The Majority In Mouwasat Medical Services Company's (TADAWUL:4002) Shares?

Jan 17
What Kind Of Shareholders Hold The Majority In Mouwasat Medical Services Company's (TADAWUL:4002) Shares?

What Makes Mouwasat Medical Services Company (TADAWUL:4002) A Great Dividend Stock?

Jan 04
What Makes Mouwasat Medical Services Company (TADAWUL:4002) A Great Dividend Stock?

Mouwasat Medical Services (TADAWUL:4002) Has Gifted Shareholders With A Fantastic 137% Total Return On Their Investment

Dec 21
Mouwasat Medical Services (TADAWUL:4002) Has Gifted Shareholders With A Fantastic 137% Total Return On Their Investment

Estimating The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)

Dec 08
Estimating The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)

Mouwasat Medical Services Company's (TADAWUL:4002) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Nov 24
Mouwasat Medical Services Company's (TADAWUL:4002) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Prognoser för vinst- och omsättningstillväxt

SASE:4002 - Analytikernas framtida uppskattningar och tidigare finansiella data (SAR Millions )
DatumIntäkterIntäkterFritt kassaflödeKassaflöde från rörelsenGenomsnittligt Antal analytiker
12/31/20274,0741,0169551,2253
12/31/20263,9278998851,11810
12/31/20253,41373461695210
12/31/20242,8796461,2561,256N/A
9/30/20242,897658542958N/A
6/30/20242,827665484874N/A
3/31/20242,764663521867N/A
12/31/20232,706658527814N/A
9/30/20232,5936598331,034N/A
6/30/20232,501625779970N/A
3/31/20232,431616517779N/A
12/31/20222,334599409707N/A
9/30/20222,226561213572N/A
6/30/20222,208581162542N/A
3/31/20222,177581313642N/A
12/31/20212,144578353683N/A
9/30/20212,125574342657N/A
6/30/20212,143593368643N/A
3/31/20212,085567287537N/A
12/31/20202,045528247481N/A
9/30/20202,016515258529N/A
6/30/20201,911447238520N/A
3/31/20201,889422255533N/A
12/31/20191,857421371635N/A
9/30/20191,808376339548N/A
6/30/20191,769364301548N/A
3/31/20191,717361202509N/A
12/31/20181,67736074386N/A
9/30/20181,652373N/A364N/A
6/30/20181,608369N/A446N/A
3/31/20181,567358N/A462N/A
12/31/20171,507337N/A452N/A
9/30/20171,435314N/A462N/A
6/30/20171,356286N/A414N/A
3/31/20171,303274N/A336N/A
12/31/20161,243257N/A306N/A
9/30/20161,144235N/A190N/A
6/30/20161,095229N/A130N/A
3/31/20161,050221N/A173N/A
12/31/20151,000209N/A207N/A
9/30/2015926206N/A271N/A
6/30/2015925235N/A306N/A
3/31/2015914238N/A301N/A
12/31/2014904240N/A286N/A
9/30/2014961240N/A268N/A
6/30/2014942212N/A267N/A
3/31/2014927207N/A281N/A

Analytiker Framtid Tillväxt Prognoser

Intäkter kontra sparande: 4002 s prognostiserade vinsttillväxt ( 13.7% per år) ligger under sparkvoten ( 14.9% ).

Resultat vs marknad: 4002 s intäkter ( 13.7% per år) förväntas växa snabbare än marknaden för SA ( 5.6% per år).

Höga tillväxtresultat: 4002 s intäkter förväntas växa, men inte avsevärt.

Intäkt vs marknad: 4002 s intäkter ( 11% per år) förväntas växa snabbare än SA marknaden ( 0.5% per år).

Hög tillväxtintäkter: 4002 s intäkter ( 11% per år) förväntas växa långsammare än 20% per år.

Tillväxtprognoser för vinst per aktie

Framtida avkastning på eget kapital

Framtida ROE: 4002 s avkastning på eget kapital förväntas bli hög om 3 år ( 21.5 %)

Upptäck tillväxtföretag

7D

1Y

7D

1Y

7D

1Y

Företagsanalys och finansiella data Status

UppgifterSenast uppdaterad (UTC-tid)
Analys av företag2025/03/06 13:23
Aktiekurs vid dagens slut2025/03/06 00:00
Intäkter2024/12/31
Årlig intjäning2024/12/31

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

PaketUppgifterTidsramExempel US-källa
Företagets finansiella ställning10 år
  • Resultaträkning
  • Kassaflödesanalys
  • Balansräkning
Analytikernas konsensusuppskattningar+3 år
  • Prognos för finansiella poster
  • Analytikernas prismål
Marknadspriser30 år
  • Aktiekurser
  • Utdelningar, splittar och åtgärder
Ägarskap10 år
  • Största aktieägare
  • Insiderhandel
Förvaltning10 år
  • Ledningsgrupp
  • Styrelse och verkställande direktörer
Viktiga utvecklingstendenser10 år
  • Företagsmeddelanden

* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om den analysmodell som används för att generera denna rapport finns på vår Github-sida, vi har också guider om hur man använder våra rapporter och tutorials på Youtube.

Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

Mouwasat Medical Services Company bevakas av 22 analytiker. 10 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

AnalytikerInstitution
Jassim Al-JubranAljazira Capital Company
Rim Ben Salah GharbiAlphaMena
Kais KriaaAlphaMena